Tissue Factor/activated Factor VIIa Induces Matrix Metalloproteinase-7 Expression Through Activation of C-Fos Via ERK1/2 and P38 MAPK Signaling Pathways in Human Colon Cancer Cell

Overview

Journal Int J Colorectal Dis

Specialties Gastroenterology
General Surgery

Date 2011 Nov 15

PMID 22076613

Citations 17

Authors

Zhi-Chao Jia

Yuan-lian Wan

Jian-Qiang Tang

Yun Dai

Yu-cun Liu

Xin Wang

Jing Zhu

Affiliations

Soon will be listed here.

Abstract

Purpose: Increased expression of tissue factor (TF) is associated with tumor invasion and metastasis in human colorectal cancer. We have previously observed that TF/FVIIa upregulates matrix metalloproteinase-7 (MMP-7) expression at the transcriptional level in colon cancer cells. MMP-7 overexpression is believed to play an important role in tumor invasion and metastasis. The aim of this study is to elucidate the molecular mechanisms by which TF/FVIIa induced MMP-7 expression and cell invasion in vitro.

Methods: Reverse transcription polymerase chain reaction, Western blot, luciferase assay, and chromatin immunoprecipitation (ChIP) were used to determine the potential mechanism and signaling pathways by which TF/FVIIa induced MMP-7 expression and cell invasion in LoVo cells. Small interfering RNA (siRNA) and cell invasion assay was used to examine whether blocking c-Fos expression could abolish FVIIa-mediated upregulation of MMP-7 and cell invasion in vitro.

Results: The results showed that FVIIa induced the upregulation of MMP-7 both at the mRNA and protein levels in a time- and dose-dependent manner and increased the invasive behavior of LoVo cells. FVIIa enhanced the promoter activity of MMP-7, and the activator protein-1 (AP-1) binding site was responsible for the activation. Site mutation of the AP-1 binding site in the promoter almost completely abolished FVIIa-mediated response. Furthermore, ChIP assay confirmed that FVIIa promoted the direct binding of c-Fos with the MMP-7 promoter in vivo. FVIIa also induced the expression and nuclear accumulation of the AP-1 subunit c-Fos. siRNA-mediated knockdown of c-Fos eliminated FVIIa-stimulated MMP-7 expression and cell migration in vitro. In addition, selective mitogen-activated protein kinase (MAPK) kinase (MEK1/2) inhibitor (PD98059) and p38 MAPK inhibitor SB203580 suppressed MMP-7 upregulation induced by FVIIa.

Conclusions: Our data suggest that a novel TF/FVIIa/MAPK/c-Fos/MMP-7 axis plays an important role in modulating the invasion of colon cancer cells and blockage of this pathway holds promise to treat colon cancer metastasis.

Citing Articles

Navel orange peel essential oil inhibits the growth and progression of triple negative breast cancer.

Yang C, Zhang W, Xiang S, Chen L, Chun J, Chen H BMC Complement Med Ther. 2024; 24(1):233.

PMID: 38877505 PMC: 11177363. DOI: 10.1186/s12906-024-04525-y.

Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.

Zou X, Zhou Q, Nie Y, Gou J, Yang J, Zhu J BMC Cancer. 2022; 22(1):595.

PMID: 35641944 PMC: 9158259. DOI: 10.1186/s12885-022-09643-9.

Protease-activated receptor-2 accelerates intestinal tumor formation through activation of nuclear factor-κB signaling and tumor angiogenesis in Apc mice.

Kawaguchi M, Yamamoto K, Kataoka H, Izumi A, Yamashita F, Kiwaki T Cancer Sci. 2020; 111(4):1193-1202.

PMID: 31997435 PMC: 7156842. DOI: 10.1111/cas.14335.

Correlation between the rs7101 and rs1063169 polymorphisms in the FOS noncoding region and susceptibility to and prognosis of colorectal cancer.

Chen H, Ji L, Liu X, Zhong J Medicine (Baltimore). 2019; 98(26):e16131.

PMID: 31261535 PMC: 6617440. DOI: 10.1097/MD.0000000000016131.

Crosstalk between TF/FVIIa and EGFR signaling in colorectal cancer cells.

Chen H, Wang X, Wan Y, Tang J Cancer Biol Ther. 2018; 20(4):454-460.

PMID: 30462558 PMC: 6422445. DOI: 10.1080/15384047.2018.1529123.

References

Shen K, Hung S, Yin L, Huang C, Chao C, Liu C . Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. Mol Cell Biochem. 2009; 333(1-2):279-91. DOI: 10.1007/s11010-009-0229-8. View

Wang W, Chen P, Wang H, Liang W, Su Y . Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis. 2006; 27(5):1113-20. DOI: 10.1093/carcin/bgi351. View

Yuan G, Qian L, Song L, Shi M, Li D, Yu M . Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells. Mol Cell Biochem. 2008; 318(1-2):73-9. DOI: 10.1007/s11010-008-9858-6. View

Maurel J, Nadal C, Garcia-Albeniz X, Gallego R, Carcereny E, Almendro V . Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer. 2007; 121(5):1066-71. DOI: 10.1002/ijc.22799. View

Aihara R, Mochiki E, Nakabayashi T, Akazawa K, Asao T, Kuwano H . Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma. Br J Surg. 2004; 92(4):454-62. DOI: 10.1002/bjs.4868. View

Yu J, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz J . Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 2004; 105(4):1734-41. DOI: 10.1182/blood-2004-05-2042. View

Kakkar A, Lemoine N, Scully M, Tebbutt S, Williamson R . Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg. 1995; 82(8):1101-4. DOI: 10.1002/bjs.1800820831. View

Wang F, So J, Reierstad S, Fishman D . Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer. 2004; 114(1):19-31. DOI: 10.1002/ijc.20697. View

Kim M, Murakami A, Kawabata K, Ohigashi H . (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis. 2005; 26(9):1553-62. DOI: 10.1093/carcin/bgi104. View

10.

Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H . Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem. 2000; 275(9):6580-5. DOI: 10.1074/jbc.275.9.6580. View

11.

Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T . Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003; 253(1-2):269-85. DOI: 10.1023/a:1026028303196. View

12.

Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y . Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2005; 231(1):20-7. DOI: 10.1177/153537020623100103. View

13.

Camerer E, Rottingen J, Gjernes E, Larsen K, Skartlien A, Iversen J . Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem. 1999; 274(45):32225-33. DOI: 10.1074/jbc.274.45.32225. View

14.

Tan X, Egami H, Abe M, Nozawa F, Hirota M, Ogawa M . Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway. J Clin Pathol. 2005; 58(12):1242-8. PMC: 1770786. DOI: 10.1136/jcp.2004.025338. View

15.

Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M . Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res. 1999; 59(14):3313-6. View

16.

Mackman N . Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004; 24(6):1015-22. DOI: 10.1161/01.ATV.0000130465.23430.74. View

17.

Jochum W, Passegue E, Wagner E . AP-1 in mouse development and tumorigenesis. Oncogene. 2001; 20(19):2401-12. DOI: 10.1038/sj.onc.1204389. View

18.

Zhang J, Wan Y, Liu Y, Wang X, Tang J, Wu T . The FVIIa-tissue factor complex induces the expression of MMP7 in LOVO cells in vitro. Int J Colorectal Dis. 2008; 23(10):971-8. DOI: 10.1007/s00384-008-0496-y. View

19.

Kasthuri R, Taubman M, Mackman N . Role of tissue factor in cancer. J Clin Oncol. 2009; 27(29):4834-8. PMC: 2764391. DOI: 10.1200/JCO.2009.22.6324. View

20.

Rickles F, Hair G, Zeff R, Lee E, Bona R . Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost. 1995; 74(1):391-5. View